Sophia Genetics Sa (SOPH)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Sophia Genetics Sa Stock (SOPH) Company Profile

Sophia Genetics Sa

Healthcare (1108)

Prossima data di guadagno

Ultimi documenti SEC

SOPH's Discussions on Twitter

Compare SOPH vs VEEV, BTSG, TEM, HQY, HNGE

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
SOPH Sophia Genetics Sa	4.88	362.54M	81.18M	-80.94M	-55.15M	-1.1809
VEEV Veeva Systems Inc	160.17	25.83B	3.20B	908.91M	1.39B	5.4168
BTSG Brightspring Health Services Inc	58.50	11.25B	13.65B	169.86M	412.12M	1.0758
TEM Tempus Ai Inc	46.18	8.35B	1.36B	-302.91M	-219.93M	-1.7182
HQY Healthequity Inc	88.11	7.25B	1.31B	215.20M	408.32M	2.4627
HNGE Hinge Health Inc	55.25	4.27B	646.34M	-512.40M	202.76M	-6.6871

Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-12-18	Iniziato	Craig Hallum	Buy
2024-08-07	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2024-06-27	Iniziato	Guggenheim	Buy
2023-11-29	Iniziato	RBC Capital Mkts	Outperform
2023-07-05	Ripresa	JP Morgan	Overweight
2023-01-03	Iniziato	BTIG Research	Buy
2022-11-23	Iniziato	Credit Suisse	Neutral
2021-10-15	Ripresa	Cowen	Outperform
2021-08-17	Iniziato	Cowen	Outperform
2021-08-17	Iniziato	Credit Suisse	Outperform
2021-08-17	Iniziato	JP Morgan	Overweight
2021-08-17	Iniziato	Morgan Stanley	Overweight

Mostra tutto

Sophia Genetics Sa Borsa (SOPH) Ultime notizie

Sophia Genetics Sa Azioni (SOPH) Dati Finanziari

Sophia Genetics Sa (SOPH)

Sophia Genetics Sa Stock (SOPH) Company Profile

Compare SOPH vs VEEV, BTSG, TEM, HQY, HNGE

Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades

Sophia Genetics Sa Borsa (SOPH) Ultime notizie

Undervalued Opportunities: Top Penny Stocks To Watch In May 2026 - Sahm

SOPHiA GENETICS (SOPH) president’s 761-share tax sale under 10b5-1 plan - Stock Titan

SOPHiA GENETICS (SOPH) CSO sells shares to cover RSU tax via 10b5-1 plan - Stock Titan

[Form 4] SOPHiA GENETICS SA Insider Trading Activity - Stock Titan

SOPHiA GENETICS (SOPH) CMO pre-planned sale of 608 shares for tax - Stock Titan

Tax-driven sale: SOPHiA GENETICS (SOPH) CLO disposes 684 shares - Stock Titan

SOPHiA GENETICS (SOPH) CPO sells 380 shares to cover RSU taxes - Stock Titan

SOPHiA GENETICS (SOPH) CSO sells 33 shares in tax sell-to-cover - Stock Titan

JURGI CAMBLONG sells shares under 10b5-1 (SOPH) - Stock Titan

Manuela Valente files Form 144 to sell SOPH shares (NASDAQ: SOPH) - Stock Titan

SOPH (NASDAQ) insider RSUs recorded; Philippe Menu reports multiple 10b5-1 sales - Stock Titan

761 RSUs filed; prior 10b5-1 sales by Ross J Muken (SOPH) - Stock Titan

Form 144: 684 RSUs flagged for sale by Morgan Stanley Smith Barney (SOPH) - Stock Titan

Rule 144: Officer/holder lists 4,608 RSUs for sale (SOPH) - Stock Titan

SOPHiA GENETICS Files Form 6-K and Publishes 2025 ESG Impact Summary - TipRanks

SOPHiA GENETICS (SOPH) publishes 2025 ESG Impact Summary for investors - Stock Titan

SOPHiA GENETICS (SOPH) CSO executes 4,000-share sale under 10b5-1 plan - Stock Titan

Insider Sell: Philippe Menu Sells 5,000 Shares of Sophia Genetics SA - GuruFocus

Director Kathy Hibbs sells SOPHiA GENETICS (SOPH) shares under 10b5-1 plan - Stock Titan

SOPHiA GENETICS (SOPH) CMO pre-planned sale of 5,000 shares - Stock Titan

Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K. - marketscreener.com

New NHS blood test aims to speed lung and breast cancer treatment - Stock Titan

SOPHiA Genetics inks two deals to advance AI for precision medicine - MSN

SOPHiA GENETICS (SOPH) CEO 10b5-1 sale of 8,500 shares - Stock Titan

TradingKey - tradingkey.com

How SOPHiA (SOPH) performance reflects its true potential (-4.63%) 2026-05-08Macro Trends - Newser

SOPHiA GENETICS schedules annual general meeting for June 18 in Switzerland - Investing.com Nigeria

SOPHiA GENETICS schedules annual general meeting for June 18 in Switzerland By Investing.com - Investing.com South Africa

SOPHiA GENETICS Calls 2026 AGM as It Highlights Breakout 2025 Growth - TipRanks

Leadership change and pay votes at SOPHiA GENETICS (Nasdaq: SOPH) - Stock Titan

SOPHiA GENETICS SA 2026 Q1ResultsEarnings Call Presentation (NASDAQ:SOPH) 2026-05-07 - Seeking Alpha

SOPHiA GENETICS (NASDAQ:SOPH) Earns Buy Rating from BTIG Research - MarketBeat

SOPHiA GENETICS S.A. (NASDAQ:SOPH) Q1 2026 Earnings Call Transcript - Insider Monkey

BTIG reiterates Sophia Genetics stock rating on strong Q1 growth - Investing.com UK

BTIG reiterates Sophia Genetics stock rating on strong Q1 growth By Investing.com - Investing.com Australia

SOPHiA GENETICS Earnings Call: Growth With Caveats - TipRanks

SOPHiA GENETICS S.A. Q1 2026 Earnings Call Summary - Yahoo Finance

SOPHiA GENETICS Q1 Earnings Call Highlights - MarketBeat

SOPHiA Genetics (SOPH) Q1 2026 Earnings Transcript - AOL.com

SOPHiA GENETICS (NASDAQ:SOPH) Releases Quarterly Earnings Results, Misses Estimates By $0.04 EPS - MarketBeat

SOPH: Q1 revenue up 22%, record platform usage, and strong margin; 2026 guidance reaffirmed - TradingView

SOPHiA GENETICS SA reports results for the quarter ended March 31Earnings Summary - TradingView

BTIG Raises its Price Target on SOPHiA GENETICS (SOPH) to $8 - Insider Monkey

SOPHiA GENETICS Posts Higher Q1 2026 Revenue but Wider Loss in Newly Filed Form 6-K - TipRanks

SOPH: Q1 2026 revenue up 22% year-over-year, with improved margins and strong global expansion - TradingView

SOPHiA GENETICS Reports First Quarter 2026 Results - ChartMill

SOPHiA GENETICS (SOPH) grows Q1 2026 revenue 22% but remains loss-making - Stock Titan

How SOPHiA (SOPH) responds to market challenges (Technical Weakness) 2026-05-05Pre-Earnings Momentum - Newser

SOPHiA GENETICS SA expected to post a loss of 23 cents a shareEarnings Preview - TradingView

SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells $24,100.00 in Stock - MarketBeat

SOPHiA GENETICS (SOPH) CMO sells 5,000 shares under 10b5-1 plan - Stock Titan

Sophia Genetics Sa Azioni (SOPH) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a SOPH